These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 35808979)
41. Discounting of medicines in Australian community pharmacies. Thai LP; Vitry AI; Moss JR Aust Health Rev; 2014 Nov; 38(5):517-22. PubMed ID: 25099433 [TBL] [Abstract][Full Text] [Related]
42. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660 [TBL] [Abstract][Full Text] [Related]
43. Reuse of single use medical devices in Canada: clinical and economic outcomes, legal and ethical issues, and current hospital practice. Hailey D; Jacobs PD; Ries NM; Polisena J Int J Technol Assess Health Care; 2008; 24(4):430-6. PubMed ID: 18828937 [TBL] [Abstract][Full Text] [Related]
44. Wastage of medicines and its financial impact on the healthcare system in the Czech Republic. Smejkalová JKJKJKTAL Ceska Slov Farm; 2018 Dec; 67(5-6):192-199. PubMed ID: 30871324 [TBL] [Abstract][Full Text] [Related]
45. Price variation among different brands of anticancer medicines available in hospital pharmacies of Nepal. Shrestha S; Poudel RS; Kc B; Poudel BK; Sapkota B; Sharma S; Khadka A J Pharm Policy Pract; 2020; 13():6. PubMed ID: 32266073 [TBL] [Abstract][Full Text] [Related]
46. Inventory Management of Health Commodities in a Tertiary Teaching Hospital in Ethiopia. Legese N; Teshome D; Gedif T Front Pharmacol; 2022; 13():763909. PubMed ID: 35479308 [No Abstract] [Full Text] [Related]
47. Taking stock of medication wastage: Unused medications in US households. Law AV; Sakharkar P; Zargarzadeh A; Tai BW; Hess K; Hata M; Mireles R; Ha C; Park TJ Res Social Adm Pharm; 2015; 11(4):571-8. PubMed ID: 25487420 [TBL] [Abstract][Full Text] [Related]
48. Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China. Wang J; Liu X; Wang S; Chen H; Wang X; Zhou W; Wang L; Zhu Y; Zheng X; Hao M Indian J Pharmacol; 2015; 47(5):535-9. PubMed ID: 26600644 [TBL] [Abstract][Full Text] [Related]
49. The price may not be right: the value of comparison shopping for prescription drugs. Arora S; Sood N; Terp S; Joyce G Am J Manag Care; 2017 Jul; 23(7):410-415. PubMed ID: 28817779 [TBL] [Abstract][Full Text] [Related]
50. Affordability of essential medicine prices in Malaysia's private health sector. Ahmad NS; Islahudin F Patient Prefer Adherence; 2018; 12():1231-1237. PubMed ID: 30038489 [TBL] [Abstract][Full Text] [Related]
51. Price, availability and affordability of medicines. Mhlanga BS; Suleman F Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401 [TBL] [Abstract][Full Text] [Related]
52. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia. Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889 [TBL] [Abstract][Full Text] [Related]
53. The prices people pay for medicines in Zimbabwe. Gavaza P; Simoyi T; Makunike B; Maponga CC Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842 [TBL] [Abstract][Full Text] [Related]
54. What does it cost to redispense unused medications in the pharmacy? A micro-costing study. Bekker CL; Gardarsdottir H; Egberts ACG; Molenaar HA; Bouvy ML; van den Bemt BJF; Hövels AM BMC Health Serv Res; 2019 Apr; 19(1):243. PubMed ID: 31014325 [TBL] [Abstract][Full Text] [Related]
55. Price comparison of high-cost originator medicines in European countries. Vogler S; Zimmermann N; Babar ZU Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050 [TBL] [Abstract][Full Text] [Related]
56. Solving the problem of access to cardiovascular medicines: revolving fund pharmacy models in rural western Kenya. Tran DN; Manji I; Njuguna B; Kamano J; Laktabai J; Tonui E; Vedanthan R; Pastakia S BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33214173 [TBL] [Abstract][Full Text] [Related]
57. Managing prices for hospital pharmaceuticals: a successful strategy for New Zealand? Tordoff JM; Norris PT; Reith DM Value Health; 2005; 8(3):201-8. PubMed ID: 15877592 [TBL] [Abstract][Full Text] [Related]
58. Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19. Pala L; Conforti F; Saponara M; De Pas T; Giugliano F; Omodeo Salè E; Jemos C; Rubatto M; Agostini A; Quaglino P; Fava P; Fierro MT; Queirolo P Semin Oncol; 2020 Oct; 47(5):302-304. PubMed ID: 32883537 [TBL] [Abstract][Full Text] [Related]
59. Competition in the off-patent medicine market in Spain: The national reference pricing system versus the regional system of tendering for outpatient prescription medicines in Andalusia. Casanova-Juanes J; Mestre-Ferrandiz J; Espín-Balbino J Health Policy; 2018 Dec; 122(12):1310-1315. PubMed ID: 30389186 [TBL] [Abstract][Full Text] [Related]
60. Inpatient Insulin Pen Implementation, Waste, and Potential Cost Savings: A Community Hospital Experience. Najmi U; Haque WZ; Ansari U; Yemane E; Alexander LA; Lee C; Demidowich AP; Motevalli M; Mackay P; Tucker C; Notobartolo C; Sartippour P; Raynor J; Zilbermint M J Diabetes Sci Technol; 2021 Jul; 15(4):741-747. PubMed ID: 33843291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]